. Earth Science News .
EPIDEMICS
Turkey approves China's Sinovac jab, Senegal in talks buy Sinopharm vaccine
by AFP Staff Writers
Ankara (AFP) Jan 13, 2021

Turkey on Wednesday approved the emergency use of a coronavirus jab developed by China's Sinovac, paving the way for a national vaccination drive that will start with healthcare workers.

Health Minister Fahrettin Koca rolled up his sleeve and received the first shot of CoronaVac after announcing plans to start administering it nationally on Thursday.

"Everyone should get vaccinated because it is the only way to get rid of this pandemic," Koca said in televised comments.

Turkey said last month that preliminary domestic testing showed 91.25-percent efficacy for CoronaVac.

But more robust trials in Brazil demonstrated an efficacy rate of around 50 percent -- much lower than those of rival shots from Moderna, Pfizer-BioNTech and Oxford-AstraZenica.

A third trial in Indonesia showed an efficacy of 65.3 percent.

"This is a safe vaccine. The safety studies have been completed," said Koca without elaborating.

Turkey has signed up for 50 million doses of CoronaVac. Twenty million of them are due to arrive by the end of the month.

It is also expected to receive 4.5 million doses of the Pfizer-BioNTech jab by late March, although negotiations are still ongoing.

The vaccinations will start with Turkey's 1.1 million health workers before moving on to those aged 65 or over and people with chronic illnesses.

Turkey has seen its official daily death tolls from the virus slip back down to under 200 after imposing weekend lockdowns and other daily restrictions in November.

The nation of 83 million people has recorded 23,325 Covid-19 deaths and more than 2.3 million virus infections.

Senegal in talks to procure Chinese-made Sinopharm vaccine
Dakar (AFP) Jan 13, 2021 - Senegal is in talks to acquire 200,000 doses of the Chinese-made Sinopharm vaccine, the government has said, intended as part of an imminent vaccination campaign against Covid-19.

The West African state is already participating in Covax, a global collaboration scheme with pharmaceutical firms to ensure equitable distribution of COVID-19 vaccines.

However Health Minister Abdoulaye Diouf Sarr said in a video posted on social media late Tuesday that, separately, Senegal is also in talks with China to procure its Covid-19 vaccine Sinopharm.

The figure of 200,000 doses is a "working basis," Sarr explained, adding that the ministry intends to begin a roll-out "very soon".

As with other countries in Africa, Senegal's infection rate is far below levels reached in the West, having recorded over 21,000 coronavirus cases since March, with 480 deaths.

The poor nation of 16 million people is nonetheless battling a second wave of Covid-19, which forced the government to impose new restrictions last week.

"As well as Covax, we have to adopt a ... national strategy," Sarr said, explaining that health workers, the elderly and people with comorbidities will be prioritised for vaccination.

Some 20 percent of Senegal's population are initially expected to be innoculated, he added, but said the government aimed to become "more ambitious with time".

Sinopharm says its vaccine is 79 percent effective against the novel coronavirus, a figure lower than those announced by its western competitors Pfizer/BioNTech and Moderna of 95 and 94 percent respectively.

On Sunday, the Indian Ocean archipelago of the Seychelles began vaccinating its population with Sinopharm -- becoming the first African nation to launch a Covid-19 vaccination campaign.

Sinopharm's vaccine is diferent from another Chinese anti-Covid jab, Coronavac.

On Tuesday, Brazil's Butantan Institute said tests on 12,500 volunteers showed that Coronavac had an efficacy of 50 percent, the minimum threshold set by the UN's World Health Organization (WHO).


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
WHO says China mission not playing blame game
Geneva (AFP) Jan 11, 2021
The World Health Organization insisted Monday that the international investigation into the Covid-19 pandemic's origins, set to start this week in China, was not looking for "somebody to blame". WHO emergencies director Michael Ryan said the delayed mission - finally given the green light by Beijing - was about science, not politics. Ten international experts will visit China from Thursday to probe the origins of the new coronavirus, more than a year after the pandemic began and amid accusatio ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Year on from first Covid-19 death, Wuhan basks in recovery

Toboggan accident crash test: Without helmet, serious injuries even at low speeds

Record number of billion-dollar disasters struck US in 2020

Migrant crossings down 13% in 2020 due to Covid: EU

EPIDEMICS
Researchers develop new one-step process for creating self-assembled metamaterials

Researchers acquire 3D images with LED room lighting and a smartphone

Massive US tech show becomes a digital event

EOS supports Texas Rocket Engineering Laboratory (TREL) to fuel additive manufacturing education

EPIDEMICS
New analysis highlights importance of groundwater discharge into oceans

Florida's water brawl with Georgia nears historic SCOTUS hearing

Sudan voices frustration as latest Nile dam talks stall

Amid Nile dam tensions, Egypt recalls Aswan 50 years on

EPIDEMICS
U.S. Navy strategic plan calls for more activity in Arctic region

The new face of the Antarctic

Researchers discover a new tool for reconstructing ancient sea ice to study climate change

Subsea permafrost is still waking up after 12,000 years

EPIDEMICS
Campaigners hail Mexican ban on genetically modified corn

Organic, non-organic meats have similar greenhouse gas impacts

Austrians press EU to talk turkey, raise farm standards

Scientists suggested a way to measure soil properties at any depth without digging

EPIDEMICS
Floods swamp roads, damage buildings in Kosovo, Albania

Strong quake hits Mongolia-Russia border: USGS

Scientists develop new approach to understanding massive volcanic eruptions

At least one dead in Morocco after heavy rains

EPIDEMICS
Lagos battles indifference as virus 'tsunami' looms

Cameroon army denies civilian 'massacre'

Rights groups urge independent probe into central Mali deaths

Tanzania inks $1.3bln railway deal with Chinese firms

EPIDEMICS
Identical twins not so identical after all: study

Earliest human culture lasted 20,000 years later than previously thought

Researchers use DNA to track original settlers of Caribbean islands

Over half of Chinese adults now overweight: official









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.